Peripheral Nerve Stimulators Market Latest Innovations, Future Scope and Market Trends

Peripheral nerve stimulators are electrical medical devices used to localize the nerve prior to the injection of anesthetic drug while performing regional anesthesia. It consists of two electrodes, (positive and negative electrode), disposable nerve-stimulator needles of different sizes and lengths, and catheter for continuous nerve block. The negative electrode is connected to the nerve-stimulator needle, while the positive electrode is attached to the skin electrode placed near the site of the nerve to be blocked. Peripheral nerve stimulators are used to access the degree of neuromuscular block in patients. The success of this type of regional anesthesia depends upon the precise location of the nerve. These devices generate small amounts of current, which results in muscular twitching, paresthesia, or combination of the both depending upon the nerve morphology. Electric pulse generated by these devices through a needle stimulates muscular twitching at very close proximity to nerve without touching it. This facilitates a high degree of accuracy for local anesthetic drug deposition surrounding the nerve. Characteristics of peripheral nerve stimulators include monophasic and rectangular shape, i.e. square wave stimulus, 0.2-0.3 msec duration, battery powered, digital display of delivered current, audible signal on delivery of stimulus, and multiple patterns of stimulation such as single twitch, train of four, double burst, and post tetanic count.

Report Overview @ 

https://www.transparencymarketresearch.com/peripheral-nerve-stimulators-market.html

Increase in popularity of regional anesthesia solely or in conjunction with general anesthesia has been boosting the demand for peripheral nerve stimulators since the last decade. The usage of peripheral nerve stimulators in regional anesthesia offers high level of comfort to anesthetists and patients as compared to the paresthesia technique. This is projected to boost the demand for these products in the near future. These devices are commonly used in orthopedic surgeries. Thus, the increase in the number of orthopedic surgical cases across the globe is expected to drive the demand for these devices. However, the high cost of these devices and availability of disposable needles and catheters for continuous blocks are the key restraining factors. Rise in number of hospitals and ambulatory surgical centers in emerging economies such as India, China, Brazil, and Mexico, and adoption of newer technologies in regional anesthesia are likely to create new opportunities for peripheral nerve stimulators during the forecast period.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28409

The market for peripheral nerve stimulators for regional anesthesia can be segmented based on stimulating feature, end-user, and geography. In terms of stimulating feature, the market can be sub-divided into peripheral nerve stimulator machines with Train of Four (TOF) monitoring features and peripheral nerve stimulator machines without TOF features. End-users of peripheral nerve stimulators include hospitals, ambulatory surgical centers, and others. The hospitals segment is projected to dominate the market during the forecast period owing to the rise in the number of government as well as private hospitals and academic medical institutions. The ambulatory surgical centers sub-segment is anticipated to witness exponential growth during the forecast period due to the rise in number of outpatient surgeries in these centers and favorable medical reimbursement policies for surgeries performed in these centers.

In terms of geography, the global peripheral nerve stimulator market for regional anesthesia can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to hold the major share of the global peripheral nerve stimulators market for regional anesthesia primarily due to the presence of well-established healthcare infrastructure, high per capita healthcare expenditure, and favorable medical reimbursement policies by governments and commercial players. Europe is also a key contributor to the global market for peripheral nerve stimulators for regional anesthesia. The market for peripheral nerve stimulators for regional anesthesia in Asia Pacific is projected to expand at a fast rate owing to the increase in number of hospitals, growth in healthcare infrastructure budgets by governments, and rise in number of orthopedic surgeries in the region.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=28409&ltype=S

Key players operating in the global peripheral nerve stimulators market for regional anesthesia include Xavant Technology (Pty) Ltd., Vygon SA, B. Braun Melsungen AG, Teleflex Incorporated, Halyard Health, Inc., and SunMed, LLC. Of these, Teleflex, B. Braun Melsungen AG, Vygon SA, and Xavant Technologies account for major share of the global peripheral nerve stimulators market for regional anesthesia.

Ambulatory EHR Market Latest Trends, Demand and Analysis 2025

The digital version of the patient’s paper chart is known as electronic health record (EHR). EHR are the patient’s record that helps the authorized users to securely access the available information about the patients. EHR includes a wide range of information such as medical history, allergies and medication, status of immunization, personal statistics, laboratory test results, demographics etc. The information on EHR can be shared across different healthcare settings through network connected systems or other information exchange systems. EHRs allow the physicians to take better decision and improved coordinated care of the patients.

Report Overview @ 

https://www.transparencymarketresearch.com/ambulatory-ehr-market.html

The global ambulatory EHR market is anticipated to grow at significant growth rate over the forecast period. Increase in usage of EHR solutions is one of the important factor attributed to the growth of the market. Automated data entry, easy execution of billing management, supporting of clinical decision, secure exchange of medical information, minimum time required for billing etc. are some of the factors driving the growth of the global ambulatory EHR market during the forecast period. Furthermore, the support from the government for adoption of HCIT (Healthcare Information Technologies), rise in demand for healthcare services etc. are few of the key factors driving the growth of the global ambulatory EHR market through 2025. Regulatory and technological uncertainties, ever increasing cost pressure, heavy infrastructure facilities are few of the factors restraining the growth of the global market over the forecast period.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28100

The global ambulatory EHR market can be segmented by application, by delivery mode, end users and by regions. Based on the application the global ambulatory EHR market can be divided into decision support, patient management, practice management, population health management, e prescribing and others. Ever increasing adoption rates of EHR among healthcare providers, the practice management segment is anticipated to hold a significant share of the global market. Based on delivery mode, the global market can be segmented into web based, on premise and cloud based.

Cloud based segment is expected to register a dominant share of the global ambulatory EHR market due to cost effective services and advantages of user friendly software models. Based on the end users the global ambulatory EHR market can be divided into private care centers and hospital owned centers. Hospital owned centers is anticipated to hold the dominant share of the global market due to ever increasing number of hospital involved in expansion, and less operational cost due to EHR etc.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=28100&ltype=S

Geographically the ambulatory EHR market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominates the market with the largest share in the global ambulatory EHR market. High adoption rate of the EHR, increased healthcare expenditure are few factors propelling the growth of the global market in the North America. Furthermore, involvement of patient, rise in awareness towards healthcare solutions etc. are few of the major contributing factor for the growth of the market in North America. Europe is also anticipated to hold a significant share of the global market followed by North America. Asia Pacific market is anticipated to register a faster growth rate during the forecast period. The Asia Pacific is the most lucrative market due rise in disposable income, adoption of healthcare solutions for better standard of life, rise in awareness towards healthcare, high penetration of digital solutions in countries such as India and China etc.

To maintain a significant position in the market the key players in the global market are operating strategies such as mergers and acquisitions, cost effective and efficient products, collaborative partnerships etc. Some of the prominent players operating in the global ambulatory EHR market are QSI Management, LLC, Allscripts Healthcare, LLC, McKesson Corporation, athenahealth, Inc. and others

3D Orthopedic Scanning Systems Market: Latest Industry Trends, Trades, Supply, Demand, Prospects by 2024

3D orthopedic scanning systems are used to scan various body parts to diagnose and treat the defects in it. 3D orthopedic scanning system can obtain accurate 3D structure of the scanned body part to producing items that are customized to the individual. These scanners find use in orthopedic surgical practices. 3D orthopedic scanning systems help to design and develop various customizations in footwear development, design of customized orthotics, and investigations for other medical and comfort purposes related to the bones and body part. 3D orthopedic scanning systems also have various clinical and research purposes. These systems help researchers to scan a number of subjects fast and easily, store and make data available for analysis and results at a convenient time and place. 3D orthopedic scanning systems are used in surgical practices such as orthopedic, spine, ENT, cosmetic, maxillofacial, dental, neurological, and general surgical procedures. Presently, most of the 3D orthopedic scanning systems available in the global market are equipped with camera, scanner, display, and memory management systems.

Report Overview @

 https://www.transparencymarketresearch.com/3d-orthopedic-scanning-systems-market.html

A number of factors affect the growth of the 3D orthopedic scanning system market. Key factors include rising demand for 3D scanning for diagnosis, development and advancement in 3D orthopedic scanner devices, and rise in global geriatric population. Other key drivers are technological advancement in scanning devices, increase in the number of cosmetic procedures, and rise in the number of orthopedic problems related to elderly population. The market is also witnessing restraints or challenges in its path such as development of other scanning technologies and stiff competition among existing 3D orthopedic scanner device manufacturers. Moreover, product recalls, government regulations for reduction of overall health care cost and subsequent upswing in bulk purchasing through INHs and GPOs (Group Purchasing Organizations) are restraining the market.

The 3D orthopedic scanning systems market can be categorized based on product type, application, and region. In terms of product type, the market can be classified into scanning system, accessories, and consumables. The scanning system segment can be further classified into sensor, camera, display, and others. The scanning system segment holds the largest share of the market. Based on application, the market can be segmented into orthopedic, spine, ENT, cosmetic, maxillofacial, dental, neurological, and others. The orthopedic segment dominates the 3D orthopedic scanning system market.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20684

Geographically, the 3D orthopedic scanning system market can be classified into five major regions: North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (Australia, New Zealand, China, Japan, India, etc.), Latin America (Brazil, Mexico, etc.), and Middle East & Africa (GCC Countries, Saudi Arabia, South Africa, etc.). North America holds the largest share of the market due to advanced technology in this region. The emerging markets in Asia Pacific, Latin America, and Middle East & Africa are expected to register robust growth during the forecast period from 2016 to 2024. This is attributed to increasing investments by the key players operating in these countries, growing health care industry, and the aging population leading to growth in the patient population in these countries. India, China, and Brazil are expected to drive growth owing to increasing investments by government bodies to enhance health care facilities.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=20684&ltype=S

Key companies operating in the global 3D orthopedic scanning system market are Elinvision, Orthopaedic Innovation Centre, TechMed 3D Inc., AGE Solutions S.r.l., FARO Technologies UK Ltd., SCANNY3D S.R.L., and 3D Systems, Inc.

OTC Orthopedic Braces Market: Emerging Technologies, Regional Trends, Competitive Landscape, Regional Analysis & Forecasts to 2024

Orthopedic braces are devices which are used to support and control the joints of the body. The braces can be used on the ankle, knee, hip, back, neck, elbow, fingers, and wrist. Orthopedic braces are used to control the position of limbs and initiate specific movement or motion in the body. Also, the braces can be compensated for weak muscles and to correct structural deformities.  Orthopedic braces are used extensively for diagnosis of cerebral palsy, spina bifida, spinal cord injury, scoliosis, and to deal with after stroke effects. Braces are also used after surgeries on knee joints in order to keep the joints immobile and control motion until the joints recover. Many people use braces for extra support to prevent injuries to joints. Athletes such as football and rugby players’ particularly use braces to prevent injuries. The sophisticated designs, cost effectiveness, and easy availability are driving the growth of the OTC orthopedic braces market. Custom braces and relevant designs can increase the cost of braces which may restrain the OTC orthopedic braces market growth rate during the forecast period.

Report Overview @

https://www.transparencymarketresearch.com/otc-orthopedic-braces-market.html

Orthotics is an example which is more than a shoe inserts. Orthotics manufacture and design orthoses which modifies the structure and function of the skeletal and neuromuscular system of the body. Demand for orthopedic braces has increased due to increase in the geriatric population, obesity, rising public participation in sports, orthopedic injuries among younger population, and rise in incidence of bone -degenerative diseases, all of which are driving growth in the OTC orthopedic braces market. According to the American Journal of Orthopedics, August 2016, osteoarthritis is a leading cause of disability among middle-aged and older adults, affecting nearly 27 million Americans. Increase in aging of the baby boomer population and rising obesity rates are estimated to increase osteoarthritis by 40% by 2025. Moreover, noninvasive nature of treatment using orthopedic braces and supports, reduced reimbursements offered during orthopedic surgery in developed regions such as North America and Europe are expected to propel the growth opportunities for sports players representing at a global, national or state level. High patient preference for alternative treatments, supports in prophylactic and rehabilitative use and lack of customization options for OTC orthopedic braces can hamper the growth of the global OTC orthopedic brace market during the forecast period.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19220

The OTC orthopedic braces market has been segmented by product type, indication, end-users, and geography. In terms of product type, the OTC orthopedic braces market is classified into foot & ankle braces, upper extremity braces, knee braces, and spinal orthoses braces. In terms of indication type, the market is classified into injury, arthritis, prophylactic, and others. According to the professor of Boston University School of Medicine, knee osteoarthritis is progressive damage to joint cartilage which leads to weakened muscles, pain and swelling. People who wore knee braces reduced pain by about 40% over 6 weeks. In terms of end users, the OTC orthopedic braces market is classified into orthopedic clinics, hospitals, pharmacies, and others. Geographically, the OTC orthopedic braces market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically North America dominates the global OTC orthopedic braces reagents market due to increase in obesity, increase in sports activity, and rise in aging  population. Reduced reimbursement policy for surgeries and low cost of braces is expected to drive the OTC orthopedic braces reagents market in North America. Europe is the second largest market for OTC orthopedic braces reagents as there are favorable government policies regarding healthcare infrastructure and awareness programs.  Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyles, rising interest in sports activity among the population, and increasing per capita expenditure. In addition, economic growth is supporting healthcare infrastructure improvement in developing countries such as Brazil, India, and China. Thus, all these factors collectively support the growth of the OTC orthopedic braces reagents market in Asia Pacific and Latin America.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=19220&ltype=S

The major players operating in the global OTC orthopedic braces reagents market include ALCARE Co., Ltd., DJO Finance LLC, DeRoyal Industries Inc., Ossur hf., Breg, Inc., 3M Company, Otto Bock HealthCare, Bauerfeind AG, BSN Medical, medi GmbH & Co. KG, and Thuasne Group.

Capsule Endoscopy Market – Latest Trends and Future Growth Study by 2024

Global Capsule Endoscopy Market: Overview

Capsule endoscopy is a painless, minimally invasive procedure used for the detection of digestive disorders. In capsule endoscopy, a pill-sized endoscope is swallowed by the patient and images of the digestive tract are recorded and later examined for the diagnosis of various intestinal diseases. Capsule endoscopies are performed to detect Crohn’s disease, celiac disease, obscure gastrointestinal bleeding, tumors in the small intestine, adverse reactions to nonsteroidal anti-inflammatory drugs (NSAID), and various other conditions that inflict the digestive system. Various types of capsule endoscopes are used to examine the small bowel, esophagus, and colon. The primary components of capsule endoscopes are a camera, a transmitter, batteries, and a light source.

Report Overview @ 

https://www.transparencymarketresearch.com/capsule-endoscopes-market.html

One of the key factors driving the capsule endoscopy market is the rising incidence of gastrointestinal diseases. According to the National Institutes of Health, around 60 to 70 million Americans are affected by gastrointestinal diseases each year. In 2004 alone, an estimated 236,000 deaths, 72 million ambulatory care visits, and 4.6 million hospitalizations were attributed to gastrointestinal diseases in the U.S., with the healthcare expenditure on these diseases pegged at around US$142 bn each year.

Global Capsule Endoscopy Market: Key Trends and Opportunities

The global market for capsule endoscopy has been witnessing a steady rise in demand owing to a number of factors, including the presence of supportive government initiatives, the demand for more accurate and faster diagnostic tools, the rise in the global geriatric population, and the introduction of technologically advanced devices such as endoscopes with a longer battery life, Wi-Fi-enabled capsules, and magnetic and hybrid versions.

Request Brochure @

 https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12683

The demand for small bowel capsules has been consistent owing to their rising usage for the detection of medical conditions such as inflammatory bowel disease, small bowel neoplastic lesions, obscure gastrointestinal tract bleeding, and Crohn’s disease. The demand for colon capsules is also anticipated to witness a rise in the coming years owing to the increasing prevalence of colon cancer. The demand for less invasive diagnostic procedures in such cases is likely to push the market for colon capsule endoscopy.

Global Capsule Endoscopy Market: Regional Outlook

There are four main geographical segments of the global capsule endoscopy market: Europe, North America, Asia Pacific, and Rest of the World. North America is the clear leader in the overall capsule endoscopy market and is likely to retain its lead position through the forecast period. The increasing prevalence of colorectal cancer and gastrointestinal disorders is one of the key factors fueling this market. Other major drivers include the presence of favorable reimbursement policies, the availability of advanced healthcare infrastructure, and the rising adoption of minimally invasive endoscopy procedures.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=12683&ltype=S

The Asia Pacific capsule endoscopy market is projected to witness impressive growth in the near future owing to a surge in patient awareness levels, the rise in disposable income and healthcare spending, improving healthcare infrastructure, the presence of untapped opportunities in the area of cancer screening, and the establishment of several endoscopic training centers. A number of countries in the Middle East, North Africa, and South America are also anticipated to experience steady growth owing to the presence of an efficient workforce, rising investments in personnel training, and numerous government initiatives.

There are a number of players competing in the global capsule endoscopy market, the prominent ones being Fujifilm Holding Corporation, Olympus Corporation, RF System Lab, Chongqing Jinshan Science & Technology Co., Capso Vision Inc., IntroMedic Co., Ltd., and Given Imaging Ltd. These companies have been adopting several business strategies, such as new product development and research activities to withstand the intensifying competition in the capsule endoscopy market.

Contrast-enhanced Digital Mammography (CEDM) Market Outlook, Competitive Landscape and Forecasts to 2025

Contrast-enhanced digital mammography is an advanced modality of breast imaging, which helps in improvement of the breast cancer screening process. Contrast-enhanced digital mammography generates a contrast-enhanced, full-field, and high-resolution image of digital mammography, similar to MRI, to provide lesion vascularity details inside the breasts. The technology combines the standard, full-field digital mammography (FFDM) with a low-osmolarity, intravenous, iodinated contrast medium. Detecting malignancies in extremely dense and heterogeneous breasts with the help of MRI is difficult. Contrast-enhanced digital mammography highlights the malignant area with the help of a contrast agent, facilitating the tumor detection. In contrast-enhanced digital mammography, an iodine-based contrast medium is administered intravenously in the arm vein before capturing the mammographic image and two subsequent images at low energy and high energy are obtained. The low-energy image reveals calcification and soft tissue details. The two images are then subtracted to generate a single, contrast-enhanced digital image, which highlights the neovascularity inside the breasts. Owing to the fact that cancerous tissues take up more iodine than normal tissues, the resulting contrast-enhanced image maximizes the conspicuity of the contrast agent in the breasts. This reveals the lesions with higher neovascularity and approximately ten times the resolution of the normal breast MRI.

Report Overview @ 

https://www.transparencymarketresearch.com/contrast-enhanced-digital-mammography-market.html

The superiority of contrast-enhanced digital mammography over the breast MRI and standard mammography in detecting breast tumors, rising prevalence of the breast cancer across the globe, and cost-effectiveness of the contrast-enhanced digital mammography modality are major factors estimated to fuel the contrast-enhanced digital mammography market during the forecast period. However, lack of awareness about the contrast-enhanced digital mammography technology among the people in developing countries is anticipated to restrain the market during the forecast period.

The global contrast-enhanced digital mammography market has been segmented based on image type and end-user. Based on image type, the market has been segmented into 2D images and 3D images. The 2D images segment dominated the market in 2016, due to rising awareness about the contrast-enhanced digital mammography procedure in developing countries. On the other hand, the 3D image segment is likely to register the maximum CAGR from 2017 to 2025. It is likely to lead the global market, in terms of revenue, during the forecast period. This estimated dominance of the segment is attributable to technically efficient and high-resolution screening of tumors and easy detection of the breast cancer with the help of 3D images.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35984

Based on end-user, the global contrast-enhanced digital mammography market can be segmented into hospitals, diagnostic laboratories, clinics, and others. The hospitals segment accounted for the maximum market share in 2016, which is attributable to improved reimbursement policies for diagnostic imaging procedures and availability of well-equipped health care facilities in hospitals. The rising investment by public and private players in the health care sector is estimated to propel the hospitals segment of the global contrast-enhanced digital mammography market during the forecast period.

Geographically, the global contrast-enhanced digital mammography market has been segmented into five major regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the maximum market share in 2016, which is attributable to the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region and superiority of contrast-enhanced digital mammography over the standard MRI technique. On the other hand, Asia Pacific is likely to register the maximum CAGR from 2017 to 2025, owing to low cost of the contrast-enhanced digital mammography, shorter time required for the procedure as compared to standard MRI, and rapidly rising number of patients of breast cancer in the region. Increasing incidence of breast cancer in the U.S., and growing awareness of early detection and screening of breast cancer, are some of the major factors expected to drive the growth of the contrast-enhanced digital mammography market in North America during 2017-2025.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=35984&ltype=S

Prominent players operating in the global Contrast-enhanced Digital Mammography (CEDM) Market are Hologic, Inc., GE Healthcare, Planmed OY, and Allengers.

Anthrax Market Demand and Production Overview 2017 - 2025

Anthrax is a lethal disease affecting humans as well as animals such as goat, sheep, horses, and cattle. The causative agent is a gram positive, rod shaped bacterium Bacillus anthracis. Anthrax can spread through three main routes which include aerial route, digestive route and contact through skin. Common symptoms in human beings for respiratory infection include pneumonia and severe respiratory collapse. Gastrointestinal infection is associated with symptoms such as vomiting, severe diarrhea, loss of appetite and digestive tract infections. Anthrax skin infection develops an ulcer with black center called as eschar which is a painless necrotic patch. This form of disease is not fatal if proper treatment is provided. Diagnosis of anthrax infection is done through X-ray and CT scan of lungs, biopsy skin test and blood test for anthrax antigens. Chemiluminescence and Enzyme Linked Immunosorbent Assay (ELISA) based kits are available for diagnosis of anthrax. Anthrax has gained popularity because of its use in bioterrorism. Since long the spores of anthrax have been used for mass infection and in biological warfare. This has led countries across the world to spread awareness about the disease, and also be prepared for any biological attack. In light of past events, as a precaution, the U.S. Postal Service has also installed a biohazard detection system at major distribution centers in order to actively scan for anthrax spores being transported via mail.

Report Overview @

 https://www.transparencymarketresearch.com/anthrax-market.html

Anthrax can be cured if treated in early stages of infection. Cutaneous or skin infection can be treated with common antibiotics such as ciprofloxacin, erythromycin, tetracycline, and penicillin. There is only one vaccine for treating anthrax which is FDA approved. BioThrax manufactured by Emergent BioSolutions, Inc. is provided as pre exposure protection from anthrax infections. Elusys Therapeutics is conducting clinical trials for ETI- 204 for inhalational anthrax. Currently the study (NCT01932437) is under phase I clinical trial. In 2012, U.S. FDA approved drug for treatment of anthrax which is manufactured by GlaxoSmithKline. Raxibacumab, a human IgG1λ monoclonal antibody can be prescribed to adults as well as pediatrics with inhalational anthrax.  Various governments are also backing research for anthrax with funding and grants.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33956

PharmAthene, Inc. announced in 2010 that the Department of Health and Human Services (HHS) modified the development contract with the company by providing up to USD 78.4 million for development of anthrax vaccine SparVax. SparVax is sub unit vaccine, which comprises of a recombinant protein manufactured in E.coli. Currently the study is in phase II clinical trial. The company is also trying to develop an anti toxin under the brand name Valortim. Valortim is a human monoclonal antibody which targets PA a component of anthrax toxin. By targeting PA, Valortim is believed to protect healthy cells from being damaged by the toxins. Currently the study is under phase I clinical trial.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=33956&ltype=S

As majority of the studies are under phase II or phase I trials, outcome of such studies cannot be ascertained. With a keen eye on anthrax infection in humans by government, and existence of few market players have restricted the market growth. Although the treatment for skin infection is cost effective, inhalational and gastrointestinal anthrax treatment is expensive. Moreover the market for anthrax is concentrated to countries under threat for terrorist attacks. The market for diagnosis of anthrax also holds potential in rural areas for diagnosis of cutaneous anthrax, where animal breading is widely practiced.

Cryosurgery Equipment Market Global Competitive Analytics and Insights 2025

Cryosurgery is the application of extremely low temperature to destroy abnormal tissue. The technique has been successful in treating some types of cancer and skin disease. Extreme low temperature for cryosurgery is achieved by using liquid nitrogen or argon gas. For treatment of external conditions, liquid nitrogen is applied to the diseased skin cells with the help of a cotton swab or spraying device. To treat internal conditions, liquid nitrogen or argon gas is passed through hollow probes, which are efficiently guided by MRI or ultrasound. Cryosurgery has been successfully applied for treating cancers such as retinoblastoma, basal cell and squamous cell carcinoma, and cervical cancer. The technique is also used for treating cervical dysplasia.

Report Overview @ 

https://www.transparencymarketresearch.com/cryosurgery-equipment-market.html

Cryosurgery is a minimally invasive procedure. Increasing prevalence of cancer in developing countries is likely to drive the growth of the cryosurgery equipment market. Moreover, as the application is localized and restricted to abnormal tissues, healthy tissue is maintained and side-effects are reduced. Cryosurgery treatment can also be used in combination with other methods such as hormone therapy, radiation and chemotherapy leading to the reduction in use of drugs causing harmful side effects. Cry-Ac, Cryoalfa, CryoClear, CryoPen, Verruca-Freeze, Premier CryOmega, and CryoProbe are examples of cryosurgery products.

According to World Health Organization, cervical cancer is the fourth most common cancer in women, and the seventh overall, with an estimated 528,000 new cases in 2012. There were an estimated 266,000 deaths from cervical cancer worldwide in 2012, accounting for 7.5% of all female cancer deaths. Almost nine out of ten (87%) cervical cancer deaths occur in less developed regions. According to Centers for Disease Control and Prevention (CDC), in 2014, 12,578 women in the United States were diagnosed with cervical cancer and 4,115 women in the country died from this cancer.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32429

The cryosurgery equipment market is segmented by product type, application, end user, and geography. Based on products, the market is segmented into systems and consumables. Based on application, the market is segmented into cancer, skin tags, skin tumors and others. Based on end user, the market is segmented into hospitals, clinics, diagnostic centers and others.

Geographically, the cryosurgery equipment market has been categorized into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to be the dominant market in terms of revenue due to increasing demand for minimally invasive procedures and technologically advanced products. Europe is expected to be the second largest market owing to increasing prevalence of cancer. According to the World Health Organization, 1 in 25,000 women die from cervical cancer in the WHO European Region. It remains the second most common cancer among women aged 15-44. The market in Asia Pacific is expected to expand at the highest CAGR during the forecast period due to increasing prevalence of cancer in the region. According to National Center for Biotechnology Information, every year in India, 122,844 women are diagnosed with cervical cancer and 67,477 die from the disease. India has a population of 432.2 million women aged 15 years and older who are at risk of developing cancer. The Latin America cryosurgery equipment market is expected to grow due to increasing demand for minimally invasive procedures. The Middle East & Africa region is expected to witness growth due to increasing disposable income and establishment/expansion of Western companies (North America and Europe) in the regions.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=32429&ltype=S

Major players operating in the cryosurgery equipment market include Brymill Cryogenic Systems, Cortex Technology ApS, Wallach Surgical Devices, CryoSurgery, Inc., CryoIQ AB, Cryoswiss GmbH, Medtronic, CryoConcepts LP, and Zimmer MedizinSystems among others

Western Blot Processors Market Analysis & Key Business Strategies by Leading Industry Players

Western blot, also known as immunoblot, is a laboratory bio-analytical method employed to detect specific protein molecules from a complex mixture of protein samples. The western blotting method is widely used in the cell & molecular biology discipline to detect proteins of interest and to quantify a gene product in gene expression studies. This method is also applied to measure the size and amount of protein expression. This method basically involves three major steps: separation of protein molecules by size, transfer of proteins to the solid membrane, and marking the desired protein using primary and secondary antibodies for visualization. High sensitivity and specificity are two key advantages offered by western blot methods. By using this method, a researcher can detect desired protein even with a concentration ten times lower limit of detection. Western blot processors are available in two different types: semi-automatic and fully automated. The manual western blot processing is time-consuming and labor-intensive, which generates the demand for automated western blot processors. Western blot processors offer several benefits. These processors automate all steps of membrane processing; they can process multiple membranes simultaneously; automatically collect primary antibodies; and effectively mix reagents inside trays.

Report Overview @ 

https://www.transparencymarketresearch.com/western-blot-processors-market.html

The global western blot processors market is projected to expand significantly in the next few years, owing to factors such as increasing prevalence of HIV/AIDS across the globe, growing use of the western blot method in proteomics and genetic science, and rising R&D budgets of pharmaceutical and biotechnology companies. Also, the western blot method is employed to confirm the hepatitis B infection and for the diagnosis of Lyme disease. The increasing prevalence of these diseases is anticipated to drive the western blot processors market during the forecast period. However, factors such as high cost of automated western blot processors and possibility of obtaining false or subjective results are anticipated to restrain the western blot processors market in the near future.

The global western blot processors market can be segmented based on type, end–user, and geography. Based on type, the market has been segmented into semi-automated and automated western blot processors. The semi-automated western blot processors segment dominated the market in 2016, but it is likely to lose market share to the automated western blot processors segment by 2025. The automated segment is projected to expand at a significant growth rate during the forecast period, owing to rising inclination toward laboratory automation and increasing laboratory workflow. Based on end–user, the global western blot processors market has been segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and academic & research institutes. The hospitals & diagnostic centers segment accounted for a leading market share in 2016 and is projected to gain market share by 2025. Growth of the segment is attributable to rising incidence of HIV/AIDS and increasing number of and demand for hospitals and diagnostic centers in developing countries.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31526

Geographically, the global western blot processors market has been segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and is anticipated to lose market share to Europe and Asia Pacific between 2017 and 2025. Europe followed North America in 2016, holding the second-largest share of the market. The market in Asia Pacific is projected to expand at the maximum CAGR during the forecast period, due to increasing health care budgets and rising investments in the biopharmaceutical sector in emerging economies such as India, China, and Malaysia. Also, rising incidence of HIV/AIDS in this region would propel the demand for western blot processors in Asia Pacific during the forecast period. According to avert.org, in 2016, more than 5.1 million people were living with HIV/AIDS and more than 270,000 new cases of HIV infection were diagnosed in Asia Pacific.

Pre Book @ 

https://www.transparencymarketresearch.com/checkout.php?rep_id=31526&ltype=S

Key players operating in the global western blot processors market are GE Healthcare, PerkinElmer, Inc., Merck Millipore, Thermo Fisher Scientific, Inc., Li-Cor Biosciences, Bio-Rad Laboratories, Inc., Advansta Inc., Cytoskeleton, Inc., Bee Robotics Ltd., and Trinity Biotech plc.

Medical Electronics Market Pegged for Robust Expansion During 2017 - 2025

Electronic devices are increasingly used for therapy, diagnosis, and rehabilitation in the field of medicine. Electromechanical equipment and medical electronics have become indispensable for providing better services to patients. Medical electronics is a branch of electronics in which medical equipment and instruments are used for medical applications such as research, diagnosis, therapy, anesthesia control, surgery, and cardiac control. Medical electronics engineering integrates medicine and environmental science with engineering practices and theories. Semiconductors have become an integral part of medical electronics equipment for reducing the cost which is changing the affordability of equipments. Medical electronic equipment are indispensable for proving better services to patients in hospitals.

Report Overview @ 

https://www.transparencymarketresearch.com/medical-electronics-market.html

In medical electronics by using precise and sophisticated equipment, medical science examines, cures and treats almost all the diseases. Benefits associated with the use of medical electronic technologies include remote health data availability, precise billing mechanism, improvement in the quality of health care, increase in output accuracy, easy to update patient records, and rise in the level of patient experience. Rapid advancement in IT and increasing health care consciousness has accelerated the scope for medical electronics market. Advanced technology in medical electronics include telehealth in intensive care unit (ICU), emergency department (ED) and hospital ward and skilled nursing facility (SNF). With the advent of digital stethoscopes, digital X-ray systems and handheld smart phone-sized ultrasound systems, conventional medical devices have evolved to aid medical electronics market. Rapid advancement in health care consciousness and information technology has accelerated the scope for medical electronics market. Growth in medical electronics market is influencing various demographic trends such as enhanced portability of complex monitoring and imaging systems, increase in household medical electronics equipment, and functional integration of applications and equipment in network and wireless technology.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34568

Rising geriatric population and increasing use of respiratory care devices are fuelling the medical electronics market. Additionally, factors such as demand for easy-to-use, personalized & advanced healthcare devices, changing lifestyle, and rising adoption of wearable electronics are expected to drive the medical electronics market. However, issues regarding cybersecurity, where health care providers and patients are subjected to security breaches and malware infections are expected to hinder the market. Rising demand for better and improved health care and developments in newer medical technologies for wireless medical devices and its technology are expected boost the medical electronics market. Moreover, factors such as increased market penetration rate of portable medical devices, increasing trend of remote patient monitoring, and high availability of electronic components such as memory devices, display technologies and microcontrollers are expected to create growth opportunities for medical electronics market. With advancement in technology, newer medical electronics devices are emerging in healthcare which is also expected to boost growth in medical electronics market.

Pre Book @  

https://www.transparencymarketresearch.com/checkout.php?rep_id=34568&ltype=S

The global medical electronics market can be segmented based on product type, application, component, and region. In terms of product type, the market can be segmented into invasive and non-invasive. Based on application, the market is classified into diagnosis, monitoring, and treatment. In terms of component, the market is categorized into sensors, batteries, memory devices, microcontrollers, and displays. Based on geography the global medical electronics market is segmented into North America, Asia Pacific, Middle-East & Africa (MEA), South America, and Europe. North America is expected to dominate the market during the forecast period owing to the increase in demand for medical electronics and improved health care infrastructure.

Key players operating in the global medical electronics market are Texas Instruments Inc., GE Healthcare Pvt. Ltd, STMicroelectronics N.V., NXP Semiconductors N.V., Medtronic PLC., Cypress Semiconductor Corporation, Analog Devices, Inc., On Semiconductor Corporation, Siemens Healthcare Private Limited, and Philips Healthcare Pvt. Ltd.